M. Imoto

IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION

T. Imai, M. Hashimoto, M. Imoto, 2005, Drug Metabolism and Disposition.

Vasohibin induces prolyl hydroxylase‐mediated degradation of hypoxia‐inducible factor‐1α in human umbilical vein endothelial cells

S. Honda, S. Soeda, A. Sakata, 2012, FEBS letters.

Pyriproxyfen enhances the immunoglobulin G immune response in mice

Tomomitsu Satho, F. Miake, T. Sharmin, 2013, Microbiology and immunology.

Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.

H. Aramaki, I. Yamamoto, Kazuhito Watanabe, 2011, Journal of pharmaceutical sciences.

Covalent binding of nitroso-sulfonamides to glutathione S-transferase in guinea pigs with delayed type hypersensitivity.

Y. Ishii, R. Eyanagi, S. Soeda, 2012, International immunopharmacology.

Permeability of 5-fluorouracil and its prodrugs in Caco-2 cell monolayers: evidence for shift from paracellular to transcellular transport by prodrug formation

I. Yamamoto, T. Imai, M. Otagiri, 2009 .

Expression and secretion of cholera toxin B subunit in lactobacilli.

Tomomitsu Satho, F. Miake, T. Sharmin, 2013, Biological & pharmaceutical bulletin.

The stimulatory effects of caffeine with oseltamivir (Tamiflu®) on light–dark behavior and open-field behavior in mice

Shigenori Watanabe, Satoko Nishimura, R. Eyanagi, 2010, Neuroscience Letters.